等待開盤 11-19 09:30:00 美东时间
-0.150
-1.65%
StoneX analyst Bruce D. Jackson downgrades Harvard Bioscience (NASDAQ:HBIO) from Speculative Buy to Hold.
11-11 21:30
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or "Harvard Bioscience"), a global leader in life science research tools, today announced preliminary financial results for the fourth quarter ended December 31,
02-10 20:38
Harvard Bioscience restructures production, closing MA plant, shifting output to US and abroad. Savings expected, costs until 2027.
01-30 19:49
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
Harvard Bioscience appoints John Duke to its board of directors, effective June 2, 2025. Duke will serve on the audit and nominating/governance committees. Katherine Eade becomes Lead Independent Director, while Thomas Loewald retires from the board.
2025-06-02 20:57